"Designing Growth Strategies is in our DNA"

Hereditary Angioedema Treatment Market Size, Share and Industry Analysis by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), By Application (Prophylaxis, Treatment), By Route of Administration (IV, Subcutaneous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, others), and Regional Forecast 2018-2025

The global hereditary angioedema treatment market size was USD 1,883.1 million in 2017 and is projected to reach USD 6,533.3 million by the end of 2025, exhibiting a CAGR... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Apr, 2019 | Report ID: FBI100164 | Status : Published

 

Request Sample PDF

Refresh Button
Hereditary Angioedema Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2017
  • 2014-2016
  • 125
  • Choose License Type
  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X